ANTIBIOTIC USE IN ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT SOC TRANG PROVINCIAL GENERAL HOSPITAL IN 2024
Main Article Content
Abstract
Background: Chronic Obstructive Pulmonary Disease is one of the three leading causes of death worldwide. Acute exacerbations are critical events in the disease progression, often caused by lower respiratory tract infections. Appropriate antibiotic use is essential to control infections and minimize the risk of drug resistance. Therefore, this study was conducted to evaluate the current status and appropriateness of antibiotic useand to contribute to the optimization of drug management strategies at the facility. Objectives: To evaluate the current status and appropriateness of antibiotic use in treating acute exacerbations of Chronic Obstructive Pulmonary Disease at Soc Trang General Hospital. Materials and methods: A cross-sectional study was conducted on the medical records of patients with acute exacerbations of Chronic Obstructive Pulmonary Disease treated as inpatients from January 1, 2024, to December 31, 2024, who were prescribed antibiotics. Appropriateness was assessed based on Decision Number 2767 of the Ministry of Health. Results: The patients had a mean age of 71.5 years, with males accounting for 89.4%. Hypertension was the most common comorbidity at 46.3%. Moderate exacerbations accounted for 83.3%, and purulent sputum symptoms were recorded in 61.2% of cases. Dual antibiotic therapy predominated at 63.0%; among which levofloxacin, ceftriaxone, and piperacillin + tazobactam were the most frequently used. The median duration of antibiotic use was 5 days. The rate of appropriate antibiotic indication according to the Ministry of Health was 61.2%. Conclusions: The study recorded a 61.2% appropriateness rate for antibiotic indications; however, this rate may not fully represent clinical reality due to its dependence on the level of detail in medical record documentation and specific pathological situations.
Keywords
Chronic Obstructive Pulmonary Disease, exacerbation, antibiotics, appropriateness
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
2. Meghji J, Mortimer K, Agusti A, et al. Improving lung health in low-income and middleincome countries: from challenges to solutions. Lancet. 2021. 397(10277), 928-940. doi:10.1016/s0140-6736(21)00458-x.
3. Nguyễn Thị Thu Thảo, Võ Thị Kim Hoàng, Võ Phạm Minh Thư, Đỗ Thị Thanh Trà. Tình hình, đặc điểm một số kiểu hình bệnh nhân bệnh phổi tắc nghẽn mạn tính ngoài đợt cấp tại Bệnh viện Trường Đại học Y Dược Cần Thơ. Tạp chí Y Dược học Cần Thơ. 2023. (39), 192-198, https://tapchi.ctump.edu.vn/index.php/ctump/article/view/861.
4. MacLeod M, Papi A, Contoli M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact. Respirology. 2021. 26(6), 532-551. doi:10.1111/resp.14041.
5. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị bệnh phổi tắc nghẽn mạn tính (Ban hành kèm theo Quyết định số 2767/QĐ-BYT). 2023. 86.
6. Nguyễn Thắng, Hoàng Phước Sang. Đánh giá tình hình sử dụng kháng sinh trong đợt cấp bệnh phổi tắc nghẽn mạn tính tại một bệnh viện ở khu vực Đồng bằng Sông Cửu Long năm 20222023. Tạp chí Y học Việt Nam. 2024. 540(2), 255-259, doi:10.51298/vmj.v540i2.10393.
7. Trần Thị Xuân, Trần Ngọc Sơn, Phạm Thị Ánh Xuân, et al. Thực trạng chuyển đổi đường dùng kháng sinh từ đường tiêm truyền sang đường uống tại Khoa Nội tổng hợp I, Bệnh viện Đa khoa Xanh Pôn. Tạp chí Y học Việt Nam. 2024. 541(1), 198-202. doi:10.51298/vmj.v541i1.10653.
8. Varol Y, Karakurt Z, Çırak AK, Şahin HD, Kıraklı C, et al. Inappropriate Utilization of Antibiotics in COPD Exacerbations. Turk Thorac J. 2020. 21(6), 397-403. doi:10.5152/TurkThoracJ.2020.19074.
9. van Brummelen S, Tramper-Stranders G, Jonkman K, de Boer G, In 't Veen J, et al. Antibiotic Prescriptions in Hospitalized Patients with an Exacerbation COPD and a Proven Influenza or RS Virus Infection. Int J Chron Obstruct Pulmon Dis. 2022. 17, 1261-1267. doi:10.2147/copd.S361841.